Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Genpact Limited is an information technology services business based in the US. Genpact shares (G) are listed on the NYSE and all prices are listed in US Dollars. Genpact employs 115,300 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $42.92 |
|---|---|
| 52-week range | $37.57 - $53.71 |
| 50-day moving average | $42.26 |
| 200-day moving average | $46.50 |
| Wall St. target price | $52.73 |
| PE ratio | 22.0103 |
| Dividend yield | $0.448 (1.16%) |
| Earnings per share (TTM) | $1.95 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $42.92 from 2022-07-01
| 1 week (2022-06-24) | -0.58% |
|---|---|
| 1 month (2022-06-03) | -3.64% |
| 3 months (2022-04-05) | -2.19% |
| 6 months (2022-01-05) | -17.87% |
| 1 year (2021-07-02) | -6.84% |
|---|---|
| 2 years (2020-07-02) | 17.40% |
| 3 years (2019-07-05) | 11.39% |
| 5 years (2017-07-03) | 53.95% |
Valuing Genpact stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Genpact's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Genpact's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 22x. In other words, Genpact shares trade at around 22x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Genpact's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.7. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Genpact's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Genpact's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $666.9 million.
The EBITDA is a measure of a Genpact's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $4.1 billion |
|---|---|
| Operating margin TTM | 12.41% |
| Gross profit TTM | $1.4 billion |
| Return on assets TTM | 6.59% |
| Return on equity TTM | 20.82% |
| Profit margin | 9.03% |
| Book value | $9.98 |
| Market capitalisation | $7.9 billion |
TTM: trailing 12 months
Dividend payout ratio: 18.9% of net profits
Recently Genpact has paid out, on average, around 18.9% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.16% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Genpact shareholders could enjoy a 1.16% return on their shares, in the form of dividend payments. In Genpact's case, that would currently equate to about $0.448 per share.
While Genpact's payout ratio might seem low, this can signify that Genpact is investing more in its future growth.
Genpact's most recent dividend payout was on 23 June 2022. The latest dividend was paid out to all shareholders who bought their shares by 8 June 2022 (the "ex-dividend date").
Over the last 12 months, Genpact's shares have ranged in value from as little as $37.5746 up to $53.7136. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Genpact's is 1.4047. This would suggest that Genpact's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Genpact Limited provides business process outsourcing and information technology (IT) services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Banking, Capital Markets and Insurance; Consumer Goods, Retail, Life Sciences and Healthcare; and High Tech, Manufacturing and Services. The company offers CFO advisory services; and environmental, social, and governance (ESG) services, such as data management, carbon accounting, human rights assessment, sustainability diligence, and ESG reporting. It also provides finance and accounting services, which include accounts payable, such as document management, invoice processing, approval and resolution management, and travel and expense processing; invoice-to-cash services, including customer master data management, credit and contract management, fulfillment, billing, collections, and dispute management services; record to report services comprising accounting, treasury, tax, product cost accounting, and closing and reporting services; financial planning and analysis consisting of budgeting, forecasting, and business performance reporting; and enterprise risk and compliance services, including operational risks and controls. In addition, the company provides supply chain advisory services, and after-sales services; sourcing and procurement services comprising direct and indirect strategic sourcing, category management, spend analytics, procurement operation, and master data management; and sales and commercial services, including campaign, order, and dispute management, lead generation, pricing, and promotion optimization. Further, it offers IT services, which comprise end-user computing support, infrastructure management, application production support, and database management services; and transformation services that include digital solutions, consulting services, and analytics services and solutions. The company was founded in 1997 and is based in Hamilton, Bermuda.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.